Silencing hepatic MCJ attenuates non-alcoholic fatty liver disease (NAFLD) by increasing mitochondrial fatty acid oxidation

Journal: Nature Communications

Published: 2020-07-03

DOI: 10.1038/s41467-020-16991-2

Affiliations: 16

Authors: 26

Go to article
Institutions Share
Biomedical Research Networking Center in Hepatic and Digestive Diseases (CIBEREHD), Spain 0.19
Center for Cooperative Research in Biosciences (CIC bioGUNE), Spain 0.15
Department of Medicine, UVM, United States of America (USA) 0.13
Department of Immunology and Microbiology, CU Anschutz, United States of America (USA) 0.10
Instituto de Investigación Marqués de Valdecilla (IDIVAL), HUMV, Spain 0.08
Alnylam Pharmaceuticals, Inc., United States of America (USA) 0.08
Faculty of Medicine and Nursing, UPV/EHU, Spain 0.06
BioCruces Health Research Institute, Spain 0.06
Instituto de Investigación Sanitaria Hospital Universitario de La Princesa (IP), Spain 0.04
Department of Epidemiology, Dartmouth College, United States of America (USA) 0.03
Department of Pharmacology and Toxicology, Dartmouth College, United States of America (USA) 0.03
Department of Community and Family Medicine, Dartmouth College, United States of America (USA) 0.03
Inflammation and Macrophage Plasticity Laboratory, CIC bioGUNE, Spain 0.02
Pakea Bizkaia, Spain 0.02
Ikerbasque - Basque Foundation for Science, Spain 0

Return

Except where otherwise noted © 2021 Springer Nature Limited. All Rights Reserved.
partner of AGORA, HINARI, OARE, INASP, ORCID, CrossRef and COUNTER